http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1380682-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d037bc74e34c7d73dd883f208aef0518 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-24 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-24 |
| filingDate | 1972-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1975-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1380682-A |
| titleOfInvention | Aminoisoquinolines |
| abstract | 1380682 2-Aminoisoquinoline derivatives GRUPPO LEPETIT SpA 7 Sept 1972 [12 June 1972] 41593/72 Heading C2C The invention comprises compounds of formula wherein one of X, Y is O and the other is H 2 ; R is H, up to C 8 alkyl or alkynyl, up to C 8 alkenyl (possibly substituted by Ph, which may be substituted), cycloalkenyl, C 1-8 alkylsulphonyl or PhSO 2 ; and R 1 is up to C 8 alkenyl (possibly substituted as above) or alkynyl, or cycloalkenyl, or RR 1 N is* optionally substituted Phup to C 8 -alkenylideneamino. These compounds are prepared by (a) reacting a corresponding compound where R 1 is H, with R 1 - halide, (b) hydrolysing a compound where R is C 1-8 alkylsulphonyl or PhSO 2 , to obtain the compounds where R is H, or (c) in case *, reacting a compound where R = R 1 = H with an appropriate arylalkenal. Therapeutic compositions for oral, parenteral or rectal administration comprise compounds of the above formula, which have antiinflammatory activity. |
| priorityDate | 1972-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 15.